Etelcalcetide

Introduction: What is Etelcalcetide?

Etelcalcetide is a medication primarily used to manage secondary hyperparathyroidism in patients with chronic kidney disease (CKD) who are on dialysis. It is a synthetic peptide that acts as a calcimimetic, activating the calcium-sensing receptor, helping to regulate parathyroid hormone (PTH) levels. By lowering PTH levels, Etelcalcetide plays a crucial role in maintaining bone health and mineral balance in patients with kidney issues.

Uses of Etelcalcetide

Etelcalcetide is specifically approved for the treatment of secondary hyperparathyroidism in adults with CKD who are undergoing hemodialysis. This condition occurs when the parathyroid glands produce too much PTH due to low calcium levels, often seen in patients with kidney failure. By controlling PTH levels, Etelcalcetide helps prevent complications such as bone disease and cardiovascular issues associated with high PTH levels.

How It Works

Etelcalcetide works by acting on the calcium-sensing receptors in the parathyroid glands. In simple terms, it tricks the body into thinking there is enough calcium present, which leads to a decrease in the production of PTH. Lowering PTH levels helps to reduce the release of calcium from bones and promotes better calcium absorption in the intestines, ultimately helping to maintain a healthy balance of calcium and phosphorus in the body.

Dosage and Administration

Etelcalcetide is administered via injection, typically given by a healthcare professional. The standard dosage for adults is usually initiated at 5 mg, administered intravenously at the end of each dialysis session. Depending on the patient's response and PTH levels, the dosage may be adjusted in increments of 2.5 mg or 5 mg, with a maximum recommended dose of 15 mg per session. Pediatric dosing has not been established, and it is essential to follow a healthcare provider's guidance for any adjustments.

Side Effects of Etelcalcetide

Common side effects

• Nausea
• Vomiting
• Diarrhea
• Muscle spasms
• Fatigue

Serious side effects

• Hypocalcemia (low calcium levels)
• Allergic reactions (rash, itching, swelling)
• QT prolongation and ventricular arrhythmias secondary to hypocalcemia

Patients should report any unusual symptoms to their healthcare provider promptly.

Drug Interactions

Etelcalcetide may interact with other medications, which can affect its efficacy or increase the risk of side effects. Major drug interactions include:

• Medications that lower serum calcium (e.g., other calcimimetics or drugs affecting calcium balance)
• Other medications that affect calcium levels

It is crucial for patients to inform their healthcare provider about all medications, supplements, and herbal products they are taking to avoid potential interactions.

Benefits of Etelcalcetide

The clinical advantages of using Etelcalcetide include:

• Effective reduction of PTH levels, leading to improved bone health.
• Lower risk of complications associated with secondary hyperparathyroidism.
• Convenient administration via injection during dialysis sessions.
• Intravenous administration avoids pill burden associated with oral therapies.

Contraindications of Etelcalcetide

Etelcalcetide should be avoided in certain populations, including:

• Patients with a known hypersensitivity to the drug or its components.
• Individuals with hypocalcemia, as it may worsen their condition.
• Pregnant women unless the potential benefit justifies the potential risk; caution is advised during breastfeeding.

Precautions and Warnings

Before starting Etelcalcetide, patients should undergo lab tests to monitor calcium and phosphorus levels. Regular monitoring is essential to prevent complications such as hypocalcemia. Patients with a history of seizures or those on medications that lower calcium levels should use Etelcalcetide with caution. Severe hypocalcemia may lead to seizures, hypotension, or cardiac arrhythmias; calcium levels should be closely monitored.

FAQs

What is Etelcalcetide used for?

Etelcalcetide is used to treat secondary hyperparathyroidism in patients with chronic kidney disease on dialysis.

How is Etelcalcetide administered?

It is given as an injection, typically at the end of each dialysis session.

What are the common side effects?

Common side effects include nausea, vomiting, and muscle spasms.

Can Etelcalcetide be used in children?

The safety and effectiveness of Etelcalcetide in pediatric patients have not been established.

What should I do if I miss a dose?

Contact your healthcare provider for guidance on what to do if you miss a dose.

Are there any dietary restrictions while taking Etelcalcetide?

Discuss dietary restrictions with your healthcare provider, as they may vary based on individual health needs.

Can I take other medications with Etelcalcetide?

Inform your doctor about all medications you are taking to avoid potential interactions.

What should I monitor while on Etelcalcetide?

Regular monitoring of calcium and phosphorus levels is essential.

Is Etelcalcetide safe during pregnancy?

It is not recommended during pregnancy unless necessary, as it may pose risks.

How long will I need to take Etelcalcetide?

The duration of treatment will depend on your individual health needs and response to the medication.

Brand Names

Etelcalcetide is marketed under the brand name Parsabiv.

Conclusion

Etelcalcetide is a vital medication for managing secondary hyperparathyroidism in patients with chronic kidney disease on dialysis. By effectively lowering PTH levels, it helps prevent serious complications associated with this condition. Patients should work closely with their healthcare providers to ensure safe and effective use of this medication.